Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Shouki Bazarbashi, MD
Woman and Man Max 99 years
Shouki Bazarbashi, MD
Update Il y a 4 ans
Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer
Phase II Study of Neo-adjuvant Chemoradiotherapy using infusional Gemcitabine followed by Surgery for Locally Advanced (T3 and T4 or Node positive) Rectal Adenocarcinoma.
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Shouki Bazarbashi, MD
Update Il y a 4 ans
First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Shouki Bazarbashi, MD
Update Il y a 4 ans
Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder
Phase II Trial of concurrent administration of intravesical BCG & Interferon in the treatment and prevention of recurrence of superficial transitional carcinoma of the urinary bladder.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Shouki Bazarbashi, MD
Update Il y a 4 ans
Pilot Trial of Pre-operative Chemo/RT Using Xeloda and External Beam RT Followed by Definite Surgery in Patients With Localized Rectal CA
Pilot trial of pre-operative chemo/RT using Xeloda and external beam RT followed by definite surgery in patients with localized rectal CA
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Shouki Bazarbashi, MD
Update Il y a 4 ans
A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248
A SU011248 expanded access protocol for systemic therapy of patients with metastatic Renal Cell Carcinoma who are ineligible for participation in other SU011248 protocols but may derive be...
Country
Saudi Arabia
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Shouki Bazarbashi, MD
Update Il y a 4 ans
Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)
Combined sunitinib and bevacizumab in advanced renal cell carcinoma.
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Shouki Bazarbashi, MD
Update Il y a 4 ans
Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer
The purpose of this study is to improve their outcome by either changing the chemotherapy drugs or giving them radiation therapy with concurrent chemotherapy, hoping that this will improve...
Country
None
organs
None
Specialty
None
Closed trial
More information